Cargando…
Good outcomes of living donor liver transplant in primary sclerosing cholangitis: an experience from North India
BACKGROUND: Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease. In the absence of effective medical therapy, liver transplant is the definitive treatment for advanced stage. However, recurrence of PSC after liver transplant is of concern which can lead to graft failure and m...
Autores principales: | Jadaun, Shekhar Singh, Mehtani, Rohit, Hasnain, Ana, Bhatia, Sushant, Moond, Vikash, Kumar, Mukesh, Kuhad, Vikash, Singh, Shweta, Agarwal, Shaleen, Gupta, Subhash, Saigal, Sanjiv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662766/ https://www.ncbi.nlm.nih.gov/pubmed/36376772 http://dx.doi.org/10.1007/s12072-022-10442-4 |
Ejemplares similares
-
ABO incompatible living donor related liver transplant in COVID-19 pandemic: Challenges and outcomes
por: Jadaun, Shekhar Singh, et al.
Publicado: (2022) -
Efficacy and safety of SARS-CoV-2 vaccines in living donor liver transplant recipients
por: Jadaun, Shekhar Singh, et al.
Publicado: (2022) -
Post COVID-19 mucormycosis in liver transplant recipients-Walking on a tight rope
por: Jadaun, Shekhar Singh, et al.
Publicado: (2021) -
Living donor liver transplant outcomes during the COVID-19 pandemic: does a decrease in case volume impact the overall outcomes?
por: Singh, Shweta A., et al.
Publicado: (2022) -
“Strategies of liver transplantation during the second wave - based on lessons learnt from the first wave of the SARS- COV2 pandemic”
por: Singh, Shweta A., et al.
Publicado: (2021)